Form 4: Bio-Techne Director Robert Baumgartner Reports Acquisition of Shares and Stock Options
SEC Filing
Director Robert V. Baumgartner reports acquisition of Bio-Techne Corp shares and stock options in a recent Form 4 filing.
Summary
- Robert V. Baumgartner, a director of Bio-Techne Corp, filed a Form 4 with the SEC.
- The filing reports a transaction on October 24, 2024, where Baumgartner acquired 1,462 shares of common stock at $0.
- Following the transaction, Baumgartner directly owns 44,863 shares of common stock.
- Baumgartner also acquired 3,511 stock options with an exercise price of $68.37, exercisable starting October 24, 2024, or the date of Bio-Techne's 2025 annual meeting of shareholders, and expiring on October 24, 2034.
- The filing also details Baumgartner's existing holdings of various stock options with different exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard regulatory filing detailing transactions by a company insider.
Positives
- The acquisition of shares by a director could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 10/29/2016 | Date exercisable for some stock options. |
| 10/28/2025 | Expiration date for some stock options. |
| 10/26/2017 | Date exercisable for some stock options. |
| 10/26/2026 | Expiration date for some stock options. |
| 10/25/2018 | Date exercisable for some stock options. |
| 10/26/2027 | Expiration date for some stock options. |
| 10/24/2019 | Date exercisable for some stock options. |
| 10/25/2028 | Expiration date for some stock options. |
| 10/24/2020 | Date exercisable for some stock options. |
| 10/24/2029 | Expiration date for some stock options. |
| 10/28/2021 | Date exercisable for some stock options. |
| 10/29/2030 | Expiration date for some stock options. |
| 10/27/2022 | Date exercisable for some stock options. |
| 10/28/2031 | Expiration date for some stock options. |
| 10/26/2023 | Date exercisable for some stock options. |
| 10/27/2032 | Expiration date for some stock options. |
| 10/24/2024 | Date of transaction; Date exercisable for some stock options; Date of Bio-Techne's 2025 annual meeting of shareholders. |
| 10/26/2033 | Expiration date for some stock options. |
| 10/24/2034 | Expiration date for some stock options. |
| 10/28/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.